Minnesota joins $29.6M settlement over generic drug price fixing

Minnesota joined a $29.6 million nationwide settlement with Glenmark over allegations of price fixing in generic prescription drugs. The state's share is $187,000, part of over $560,000 recovered from settlements with multiple drug makers. Consumers who purchased drugs from these companies between 2009 and 2019 may be eligible for compensation.